56 Days
Source:
الوئام
_1777294237270_124456903.png&w=64&q=75){kind=small}
U.S. Food and Drug Administration Approves "Lifvendra," First Oral Medication to Lower Cholesterol
The U.S. Food and Drug Administration has approved a new pill for lowering cholesterol, targeted at patients who do not respond to traditional treatments. The medication aims to provide an effective option for those suffering from high cholesterol levels and unable to improve their condition with standard drugs. The article did not provide further details about its effectiveness or potential side effects.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)